|
Click here to view online. Add this email to your safelist. |
|||||||||||
|
|
|||||||||||
|
Matching drug and disease omic signatures for drug repurposing |
|||||||||||
|
15 February 2023
The pace of change in healthcare is moving more rapidly than ever before. To maximise the delivery of potential new medicines, we are using data driven methods to associate existing medicines with new disease indications with the aim to make drug discovery faster and more efficient. These data driven methods allow us to apply existing chemistry to new disease areas, maximising benefits for patients. |
|||||||||||
|